FDA Label for Silky Eye Primer

View Indications, Usage & Precautions

Silky Eye Primer Product Label

The following document was submitted to the FDA by the labeler of this product Wow Ventures. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredient



Active Ingredient: Titanium Dioxide 0.77%


Inactive Ingredient



Inactive Ingredients: Cyclopentasiloxane, Talc, Isododecane, Cyclohexasiloxane, Mica (CI 77019), DisteardimoniumHectorite, Trihydroxystearin, Trimethylsiloxysilicate, VP/Hexadecene Copolymer, Polyisobutene, Bismuth Oxychloride, Silica Dimethyl Silylate, Propylene Carbonate, PEG-40 Stearate, SorbitanSesquioleate, Beeswax, Caprylyl Glycol, 1,2-Hexanediol, Ethylhexylglycerin, Dimethicone, Methicone, Tocopheryl Acetate, Iron Oxides (CI 77491), Water, Prunusserrulata flower extract, Pearl Extract, Butylene Glycol, Phenoxyethanol, Oryza Sativa (Rice) Extract, Milk Protein Extract


Purpose



Purpose: Sunscreen, Make up


Warnings



Warnings: 1. If any of the following symptoms appear on the area where the product was applied, stop using the product immediately and consult a specialist. A. Redness, swelling, itchiness, irritation or other abnormal symptoms B. Symptoms above appear after exposure to direct sunlight 2. DO NOT use the product on an area with wound, eczema, or dermatitis 3. Storage and handling. A. Make sure to close the lid after use B. Keep away from children and babies C. DO NOT store in a place with high or low temperature and direct sunlight 4. Avoid direct contact with eyes. If contact occurs, flush thoroughly with water


Description



Indications & Usage: Apply a suitable amount to your eyelid.

Dosage & Administration: Take an adequate amount of this product.


* Please review the disclaimer below.